SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1410VEGF-Trap-Eye, IMO, has little or no commercial future, which is what I’ve been DewDiligence_on_SI-11/22/2010
1409Were you wrong in 2007? finance.yahoo.com Without knowing details on the "Miljenko Zuanic411/22/2010
1408AMD results Monday morning: siliconinvestor.comDewDiligence_on_SI-11/19/2010
1407>>PFE runs into problems with their antiNGF antibody in osteoarthritis in Biomaven-9/30/2010
1406PFE runs into problems with their antiNGF antibody in osteoarthritis in that it Biotech Jim-6/24/2010
1405Rilonacept worked as a prophylactic for gout, but not as a treatment: >>Ttuck-6/9/2010
1404After so many years of "milking" regn, isn't he ashame to do transMiljenko Zuanic15/17/2010
1403prnewswire.com (Note that J. Goldstein, Nobel Laureate for lipid metabolism andBiotech Jim-5/12/2010
1402reuters.com Schleiffer discusses one of their newer therapeutic antibodies... Biotech Jim13/23/2010
1401<<Regeneron Announces Appointment of Michael Aberman, M.D., as Vice PresidMiljenko Zuanic-3/23/2010
1400Nice presentation of DA VINCI results. Overall, very solid data with indication Miljenko Zuanic22/20/2010
1399Suckers at REGN continue to sell shares at first opportunities. 30 Years of theMiljenko Zuanic12/19/2010
1398[Deleted]DewDiligence_on_SI-2/19/2010
1397From today PR:"VEGF Trap-Eye Shows Positive Results in a Phase 2 Study in PMiljenko Zuanic-2/18/2010
1396Bristol's comment comes from the data package so far which includes an earlykenhott-11/12/2009
1395Now this press release hits the wires... Sanofi-aventis and Regeneron Expand StBiotech Jim-11/10/2009
1394I saw the BMY collaboration announcement today on the IL-6 antibody with privateBiotech Jim-11/10/2009
1393Any opinion on Arcalyst in gout? Savient with their likely eventually to be apprrkrw-11/3/2009
1392OT- Thanks. Forgot about them. Too many companies to follow.kenhott-11/3/2009
1391Now here is a solid press release. Lot of excitement in the analgesia area regaBiotech Jim-11/3/2009
1390</i>UPDATE 2-Novartis says EU approves inflammatory disease drug Wed Oct 2scaram(o)uche-10/28/2009
1389Yesterday's rating change for REGN can't hurt it's near term prospecGator II-7/9/2009
1388One fewer AMD competitor: siliconinvestor.comDewDiligence_on_SI-3/7/2009
1387Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects: siliconinDewDiligence_on_SI-11/3/2008
13863Q08 Lucentis sales: siliconinvestor.comDewDiligence_on_SI-10/20/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News